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discharge, registry patients experienced a 42% reduction in NYHA
class III-IV symptoms. In-hospital mortality was numerically lower
among registry patients (2.7% vs. 4.6, p¼0.27). Need for blood
transfusions were similar in registry and clinical trial patients (9.1%
vs. 12.5%, p¼0.21). There were no differences in the occurrence of
other complications such as acute kidney failure, vascular injury or
ventricular arrhythmias.
CONCLUSIONS USpella provides a real world and contemporary
estimation of the type of procedures and outcomes of high-risk pa-
tients undergoing PCI supported by Impella 2.5. Despite the higher
risk of registry patients, clinical outcomes appeared to be favorable
and consistent compared with the randomized trial.
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BACKGROUND We sought to describe contemporary guidewire utili-
zation for antegrade wire escalation during chronic total occlusion
(CTO) percutaneous coronary intervention (PCI).
METHODS We examined guidewire and microcatheter utilization
during antegrade wire escalation attempts among 1097 CTO PCIs
performed at 13 experienced US centers between May 2012 and April
2015 using the hybrid approach.
RESULTS Mean age was 65  9.8 years, 83.2% of the patients were
men and 33.3% had prior coronary bypass graft surgery. Technical and
procedural success was 90.6% and 87.6%, respectively. Antegrade
wire escalation was used in 780 procedures (71.1%), and was the ﬁnal
successful crossing strategy in 463 procedures (59.3%). A total of 1630
guidewires (2.4  1.4 per procedure) were used for antegrade wire
escalation. The most frequently used guidewires were the Pilot 200
(Abbott Vascular, 24.7%), Fielder XT (Asahi Intecc, 19.7%), and the
Conﬁanza Pro 12 (Asahi Intecc, 12.6%) (Figure 1). The same guidewires
were the ones that most commonly led to successful CTO crossing:
Pilot 200 (35.2% of successful antegrade wire crossings), Fielder XT
(20%) and Conﬁanza Pro 12 (10.7%). A microcatheter or over-the-wire
balloon was used in 73.8% of antegrade wire escalation cases, as fol-
lows: Corsair (Asahi-Intecc, 42.8%), Finecross (Terumo, 18.6%), over-
the-wire balloon (14.2%), CrossBoss (Boston Scientiﬁc, 12.7%), and
Venture (St Jude Medical, 3.3%).CONCLUSIONS Our contemporary, multicenter CTO PCI registry demon-
strates remarkable consistency in guidewire selection for antegrade wire
escalation, with polymer-jacketed guidewires being used in most cases
including most successfully crossed cases. Upfront use of the Pilot 200
guidewire might offer the best chance for successful guidewire crossing.
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BACKGROUND The prevalence of native coronary CTO following cor-
onary artery bypass grafts (CABG) is high. At 10 years following CABG,
half patients will have at least one saphenous vein graft (SVG) occluded
and/or many SVGs will be diseased. Long-term outcome post SVG PCI is
poor, with high occlusion rate. If symptomatic, these patients may be
considered for a native coronary CTO PCI rather than SVG PCI. We
examined the feasibility and outcomes of CTO PCI using a patent or
occluded SVG as a retrograde conduit to the native CTO vessel.
METHODS Our preferred wire to cross an occluded SVG is Pilot 200
(Abbott Vascular, US) followed by amicrocatheter (MC) (usually Corsair,
Asahi Intecc, Japan), whereas standard workhorse wire can be used in
patent but diseased SVGs or arterial graft. MC tip injection is performed
to assess if the wire tracked the vein structure in case of an occluded
SVG. Clips and other surgical landmarks are used to track the occluded
graft with the wire. Once the MC is at the distal CTO cap, standard
techniques to open CTO are employed. We assessed the proportion of
patients treated with such technique from SVGs. We speciﬁcally
reviewed the J-CTO score, the prevalence of occluded vs. patent graft,
the type of graft crossed (SVG or arterial graft), technical success and
management of the graft after successful PCI of the native CTO.
RESULTS From 03.2009 to 04.2015 431 CTO PCI cases were performed
by a single operator (SR) or a teamof 2 operators (SR andCMN). Of these,
156 (36.2%) were done in post-CABG patients. In the post-CABG cohort,
an antegrade approach was used in 68 (43.6%) and a retrograde in 88
(56.4%) of cases. In the retrograde approach, septal collateral channels
(CCs) were used in 26 (29.5%), epicardial in 34 (38.6%) and SVGs in 28
(31.8%) of cases. Technical success of CTO revascularization in post-
CABG patients (J-CTO score 2.510.1) was 91%. In the sub-group treated
from an SVG,mean J-CTO score was 3.040.19. The CTO locationwas in
the right coronary artery in 43%, left circumﬂex in 43%, left anterior
descending in 7% and in the left main in 7%. When using an SVG, suc-
cess was achieved in 27 cases (96.4%). A total of 15 SVGs (53.6%) were
occluded before the retrograde attempt, and the oldest occlusion was
4-years old. Most common native coronary CTO recanalization
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and CART (11%). We did not encounter distal embolization, as nothing
larger than a microcatheter or small balloons were used in the SVG.
There was one small SVG perforation, which was coiled following CTO
PCI.We did not coil SVG if TIMI score was1 on the ﬁnal angiography of
vein graft. However, we coiled SVGs in 14 cases (50%), when residual
competitive ﬂow from the vein graft was strong enough to potentially
compromise ﬂow and outcomes of the newly open native vessel.
CONCLUSIONS Patent or occluded SVGs are very effective conduits
that allow for high success and low complication rate in CTO PCI in
post-CABG patients.
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BACKGROUND (Background) Patients with prior coronary artery
bypass grafting (CABG) often have complex coronary anatomy.
Moreover, These patients have accelerated atherosclerosis including
calciﬁcation even after CABG. Thereby, procedural success with
percutaneous coronary intervention (PCI) to chronic total occlusion
may be challenged due to lesion complexity.
METHODS (Methods) We evaluated consecutive 317 lesions under-
went CTO-PCI regarding clinical / lesion characteristics and procedural
characteristics / outcome, which were compared between patients
with (70 lesions ; PG) and without prior CABG(247 lesions ; NG).
RESULTS (Results) PG were older (N ; 69.1 +/- 10.0 vs. P ; 71.7 +/- 8.5,
p¼0.03), and had more comorbidities than the NG. As to lesion char-
acteristics, target lesions were balanced between two groups (RCA : P ;
25 / 70 (35.7%) vs. N ; 96 / 247 (38.9%), LAD : P ; 20 / 70 (28.6%)vs. N ; 57
/ 247 (23.1%), LCX : P ; 19 / 70 (27.1%) vs. N ; 81 / 247 (32.8%)) except 2
lesions to LMT-CTO in PG. In the J-CTO score, PG had a higher value
than NG (P ; 2.3 +/- 1.2 vs. N ; 1.7 +/- 1.3, p¼0.0019). In detailed
assessment of the J-CTO score, angiographic-evident-calciﬁcation-
within-CTO-segment had most impacted in PG (P ; 35 / 70 (50.0%)
vs. N; 63 / 247 (25.5%), p¼0.0004) than other parameters. Regarding
procedural characteristics / outcome, PG were treated more frequently
with the retrograde approach (P ; 29 / 70 (41.4%) vs. N ; 44 / 247(17.8%),
p¼0.0004) and had longer ﬂuoroscopic time (min.) (P ; 79.1 +/- 48.8 vs.
N ; 53.0 +/- 40.2, p<0.05)), more radiation dose (Gycm2) (P ; 504.6 +/-
288.3 vs. N ; 348.2 +/- 242.8, p<0.05)), higher amount of contrast
media (ml) (P ; 210.5 +/- 78.5 vs. N ; 190.3 +/- 69.4, p<0.05). In suc-
cessful revascularized rate, PG had a little bit lower value than the NG,
however, there were no statistic difference between two groups (P ; 56
/ 70 (80.0%) vs. N ; 210 / 247 (85.0%), p¼0.35).non CABG
n[247 (n(%))prior CABG
n[70 (n(%)) p valuethe J-CTO scoreAverage 1.7+/-1.3 2.3+/-1.2 p¼0.0019
Blunt stump 119(48.2%) 40(57.1%) p¼0.19
calciﬁcation 63(25.5%) 35(50.0%) p¼0.004
bending >45 degree 62(25.1%) 27(38.6%) p¼0.027
lesion length >20mm 92(37.2%) 34(48.5%) p¼0.09
Re-attempt 45(18.2%) 17(24.3%) p¼0.26
Procedural OutcomeSuccess revascularized rate 85.0%(210/247) 80.0%(56/70) p¼0.35
Procedural Approachconventional antegrade approach 203(82.2%) 41(58.6%) p¼0.0004
retrograde/bilateral approach 44(17.8%) 29(41.4%)bypass 0 7 *transseptal 32 10 *epicardial 12 12 *Fluoloscopic time(min.) 53.0+/-40.2 79.148.8 P<0.05
Radiation dose(Gycm2) 348.2242.8 504.6288.3 P<0.05
Amount of contrast media (ml) 190.369.4 210.578.5 P¼0.032
Number of wires per one CTO-PCI 3.32.2 4.73.1 P<0.05CONCLUSIONS (Conclusion) CTO lesions with prior CABG were more
complicated, especially in terms of calciﬁcation within CTO segment,
therefore it might be required to pursuit successful interventional
revascularization with complex procedure including higher use of the
retrograde approach.
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BACKGROUND Percutaneous coronary intervention (PCI) for chronic
total occlusion (CTO) is complex and technically challenging. Among
recent advances in interventional devices and procedural techniques,
retrograde approach has emerged as a key component to facilitate
procedural success. However, there are few evidences regarding how
to select an interventional collateral channel. We proposed a hierar-
chic decision algorithm to guide collateral channel selection. The aim
of this study was to validate this algorithm in real world practice.
METHODS From January 2012 to April 2015, consecutive retrograde
CTO PCI attempts by high-volume operators in a tertiary university-
afﬁliated hospital were enrolled. The clinical, angiographic, and
procedural details were collected. If there were multiple existing
interventional collateral channels, the selection of the ﬁrst channel
was based on a hierarchic decision algorithm of the following: size of
channel, tortuosity, the angle of attack entering distal true lumen
(the attack angle), and the distance between the emerging point and
distal cap.
RESULTS A total of 318 consecutive attempts were enrolled in this
study. The documented duration of occlusion was 24.1  27.4 months
and the J-CTO score was 4.3  0.8. Technical success rate was 93.4%,
and procedural complication rate was 3.5%. The procedure and ﬂuo-
roscopy times were 120.1  40.5 and 52.1  20.1 minutes, respectively.
The total radiation exposure and contrast medium consumption were
6.6  3.0 Gy and 304.0  92.3 ml, respectively. The atrioventricular
(AV) groove, epicardial, and septal collateral channels were used in 49
(15.4%), 105 (33.0%) and 164 (51.6%) procedures, respectively, without
signiﬁcant difference in baseline demographic and angiographic
